Core Viewpoint - Hema Medical (03309.HK) announced a share buyback of 60,000 shares at a price range of HKD 1.80 to HKD 1.81, totaling HKD 10.85 million, on November 17, 2025 [1] Company Summary - As of November 17, 2025, Hema Medical's stock closed at HKD 1.80, down 1.64%, with a trading volume of 207,800 shares and a turnover of HKD 374,300 [1] - The company has a market capitalization of HKD 2.268 billion and ranks 16th in the medical services sector [1] Financial Metrics - Return on Equity (ROE): -6.36%, compared to the industry average of 0.02%, ranking 39th out of 60 [1] - Market Capitalization: HKD 2.268 billion, while the industry average is HKD 8.332 billion, ranking 16th out of 60 [1] - Revenue: HKD 1.935 billion, with the industry average at HKD 3.832 billion, ranking 15th out of 60 [1] - Net Profit Margin: 5.95%, compared to an industry average of -843.36%, ranking 25th out of 60 [1] - Gross Profit Margin: 31.12%, while the industry average is 39.76%, ranking 28th out of 60 [1] - Debt Ratio: 29.8%, compared to the industry average of 74.15%, ranking 21st out of 60 [1]
希玛医疗(03309.HK)11月17日斥资10.85万港元回购6万股